IDH3A and neoplasm: In this study, we focused on the relationship between the overexpression of IDH3α and the acidic tumor microenvironments and confirmed whether the inhibition of IDH3α could sensitize tumors to chemoimmunotherapy by activating the cGAS–STING pathway.